- Home
- ABEO vs FDBC Comparison
ABEO vs FDBC Comparison
Compare ABEO & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | FDBC |
|---|---|---|
| Founded | 1974 | 1902 |
| Country | United States | United States |
| Employees | N/A | 324 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 317.8M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ABEO | FDBC |
|---|---|---|
| Price | $5.41 | $53.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 6.0K |
| Earning Date | 05-13-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | ★ 165.16 | 35.00 |
| EPS | N/A | ★ 2.63 |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ N/A | $20.80 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $39.87 |
| 52 Week High | $7.65 | $56.90 |
Technical Indicators
Market Signals| Indicator | ABEO | FDBC |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 55.64 |
| Support Level | $5.23 | $52.83 |
| Resistance Level | $5.55 | $56.52 |
| Average True Range (ATR) | 0.25 | 1.37 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 24.36 | 75.19 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.